Kalos Management, Inc. Cytosorbents Corp Transaction History

Kalos Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$7.65 - $8.98 $92,947 - $109,107	-12,150 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.37 - $11.54 $9,949 - $15,578	-1,350 Reduced 10.0%	12,150 $97,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $3,599 - $4,730	-608 Reduced 4.31%	13,500 $89,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $4,037 - $5,067	-592 Reduced 4.03%	14,108 $106,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $32,302 - $43,660	-2,950 Reduced 16.71%	14,700 $176,000
Q1 2018 May 14, 2018	BUY	$6.55 - $8.2 $46,505 - $58,219	7,100 Added 67.3%	17,650 $125,000
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $62,245 - $74,377	10,550	10,550 $73,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.